SCHEMBL22236138

SCHEMBL22236138

COC(=O)C1CC2=C(c3nc(Cl)c4ccccc4c3CC2C(C)(C)C)N(C)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22235460 0.90 — —
SCHEMBL22235411 0.82 — —
SCHEMBL22235400 0.72 KDM4E (0.31) —
SCHEMBL22236137 0.70 GABRG2 (0.41) —
SCHEMBL22259908 0.67 — —
SCHEMBL22235426 0.66 KDM4E (0.32) —
SCHEMBL22235748 0.66 KDM4E (0.32) —
SCHEMBL22235429 0.66 KDM4E (0.32) —
SCHEMBL22235325 0.64 MEN1 (0.30) —
SCHEMBL22236064 0.64 TP53 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3911653-A1 SUBSTITUTED POLYCYCLIC CARBOXYLIC ACIDS, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2021-11-24 — — EP disclosed
WO-2020150366-A1 SUBSTITUTED POLYCYCLIC CARBOXYLIC ACIDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2020-07-23 — — WO disclosed
Send feedback